SA PRO
Free Account
Lucid Diagnostics Inc.LUCDNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
5 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 106% higher.

Bear Case
$2.00
+65%
Consensus
$2.50
+106%
Bull Case
$3.00
+148%
Price Range5 analysts
Low
Consensus
High
$2.00
$3.00
Current Target
Current Price
$1.21
Upside to Target
$1.29

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.30(3 analysts)
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+114.84%
EPS—
FY2028
Rev+12.78%
EPS—
FY2029
Rev+46.48%
EPS—

Earnings Surprises

Beat rate:50%(6/12 quarters)
Avg surprise:-22.5%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Mar 25, 2025BTIG
Lucid Diagnostics price target lowered to $2 from $2.50 at BTIG
Target:$2.00
+29.0%from $1.55
Nov 13, 2024Needham
Needham Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
Target:$2.50
+216.5%from $0.79
May 14, 2024Canaccord Genuity
Canaccord Genuity Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
Target:$3.00
+215.8%from $0.95
Apr 8, 2024BTIG
BTIG updates Lucid Diagnostics Inc (LUCD) model post Q4 results
Target:$2.50
+169.5%from $0.93
Nov 18, 2022BTIG
BTIG Maintains Buy on Lucid Diagnostics, Lowers Price Target to $3.5
Target:$3.50
+83.2%from $1.91
Nov 15, 2022Needham
Needham Maintains Buy on Lucid Diagnostics, Lowers Price Target to $3.1
Target:$3.10
+36.6%from $2.27

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance